Clinical Trials on Glabellar Crease
Total 10000 results
-
Washington University School of MedicineTerminatedNeoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerBreast NeoplasmsUnited States
-
Organisation for Oncology and Translational ResearchUnknownLetrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenER Positive, HER2 Negative Breast CancerChina
-
National Cancer Institute, ThailandCompleted
-
St. Joseph's Hospital, FloridaTerminatedBreast Cancer Metastatic to the LiverUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory CarcinomaUnited States
-
Washington University School of MedicineCompletedBreast Cancer | Breast Cancer Female | Cancer of BreastUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, Italy, United Kingdom
-
University of WashingtonNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)CompletedDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ | Atypical Lobular Breast HyperplasiaUnited States
-
National Cancer Centre, SingaporeSingapore General Hospital; Singapore Cancer Society; Genome Institute of Singapore and other collaboratorsRecruitingLocally Advanced Breast Cancer | Early-stage Breast CancerSingapore
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedTriple Negative Breast CancerChina
-
Jewish General HospitalExactis Innovation; Genome QuebecCompletedTriple Negative Breast CancerCanada, United States
-
Universitaire Ziekenhuizen KU LeuvenCompletedBreast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative NeoplasmBelgium
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
AmgenTerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Locally Recurrent and Metastatic Breast Cancer
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer (TNBC)
-
Second Affiliated Hospital, School of Medicine,...RecruitingTNBC, Triple Negative Breast CancerChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
West China HospitalWest China Fourth Hospital, Sichuan University; The Fourth People's Hospital...Not yet recruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)China
-
First Hospital of China Medical UniversityLiaoning Cancer Hospital & InstituteNot yet recruiting
-
University of California, San FranciscoBreast Cancer Research FoundationRecruitingCancer Risk | Breast Cancer RiskUnited States
-
Duke UniversityPfizerNot yet recruitingHER2+ Metastatic Breast Cancer (MBC)
-
Beijing Friendship HospitalRecruitingInvasive Breast Cancer | Perfusion | CavitationChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
University of ArizonaNational Cancer Institute (NCI)RecruitingPsychological Distress | Breast Cancer FemaleUnited States
-
Second Affiliated Hospital, School of Medicine,...GeneCast Biotechnology Co., Ltd.RecruitingStage I-III Breast CancerChina
-
Gun Oh ChongNot yet recruitingHormone Receptor-positive Breast Cancer
-
Changhai HospitalNot yet recruitingBreast Neoplasms | Metastatic Breast Cancer | Treatment | Survival
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingBreast Cancer | Oncoplastic Breast Surgery | Aesthetic OutcomesChina
-
Sohag UniversityRecruitingStudy on Breast Cancer PatientsEgypt
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHormone Receptor-positive Breast Cancer
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Beijing 302 HospitalCompletedHR+/HER2- Advanced Breast CancerChina
-
Vanderbilt-Ingram Cancer CenterCompletedEstrogen Receptor-positive Breast CancerUnited States
-
Institut Claudius RegaudCompletedHormono-depending Adjuvant Breast CancerFrance
-
PfizerCompletedAdvanced or Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsActive, not recruiting
-
Hoffmann-La RocheCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Novartis PharmaceuticalsActive, not recruiting
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerJapan